ALCON N chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 17.64
Dividend & Yield0.20fr (0.34%)
Beta 0.74
Market capitalization 29.82B
Operating cash flow 1.27B
ESG Scores unknown

Company description

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio1.41
Working Capital0.13
Return On Equity0.02
Debt To Equity0.21
Fixed Asset Ratio0.32
Fixed Interest Cover7.51

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 44M 84M -21M 60M
Total Cashflows From Investing Activities -1B -1.01B -572M -1.2B
Net Borrowings 15M 3.29B 536M -63M
Total Cash From Financing Activities -78M 659M 466M -123M
Change To Operating Activities 66M 8M -23M 88M
Issuance Of Stock
Net Income -227M -656M -531M 376M
Change In Cash 55M 595M 735M 18M
Effect Of Exchange Rate -6M 27M 18M -6M
Total Cash From Operating Activities 1.14B 920M 823M 1.34B
Depreciation 1.64B 1.42B 1.61B 1.22B
Change To Account Receivables 53M -115M 43M -198M
Other Cashflows From Financing Activities -93M -2.63B -70M -6M
Change To Netincome -284M 290M -101M 128M
Capital Expenditures -524M -553M -479M -700M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 653M 690M 672M 703M
Income Before Tax -300M -332M -635M 418M
Net Income -227M -656M -531M 376M
Selling General Administrative 2.8B 2.8B 2.67B 3.06B
Gross Profit 3.57B 3.66B 3.06B 4.7B
Ebit 121M 95M -266M 901M
Operating Income 121M 95M -266M 901M
Interest Expense -24M -113M -124M -120M
Income Tax Expense -73M 324M -104M 42M
Total Revenue 7.15B 7.51B 6.83B 8.29B
Cost Of Revenue 3.58B 3.85B 3.78B 3.6B
Total Other Income ExpenseNet -421M -427M -369M -483M
Net Income From Continuing Ops -227M -656M -531M 376M
Net Income Applicable To Common Shares -227M -656M -531M 376M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 4.42B 8.35B 8.78B 8.74B
Total Stockholder Equity 22.64B 19.3B 18.82B 19.26B
Other Current Liabilities 613M 564M 581M 687M
Total Assets 27.06B 27.66B 27.6B 28B
Common Stock 20M 20M 20M
Other Current Assets 57M 47M 32M 31M
Retained Earnings -547M
Treasury Stock 22.64B 19.83B 18.8B 19.24B
Cash 227M 822M 1.56B 1.57B
Total Current Liabilities 1.89B 2.3B 2.26B 2.47B
Other Stockholder Equity 22.64B 19.83B 18.8B 19.24B
Property, Plant, and Equipment 2.88B 3.44B 3.78B 4.08B
Total Current Assets 3.4B 4.24B 4.99B 5.39B
Net Tangible Assets 3.31B 892M 1.55B 2.14B
Net Receivables 1.6B 1.74B 1.65B 1.79B
Accounts Payable 663M 833M 876M 903M


Insider Transactions

Here are the insider transactions of stock shares related to ALCON N:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ALCON N. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ALCON N

Here is the result of two systematic investment strategies applied to ALCON N. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ALCON N

The following chart shows the equity curve of the two systematic investment strategies applied to ALCON N:

ALCON N automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 28.37% on the backtest period.

Performance at glance

Performance

28.37 %

Latent gain

281.9 fr

Invested capital

993.78 fr

Annualized return

10.43 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ALCON N

This is the result of two momentum investment strategies applied to ALCON N. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ALCON N

The following chart shows all the entries opened by the momentum investment system on ALCON N:

ALCON N momentum entries
  • The first momentum investment strategy would give 32.38% of return on ALCON N. That represents 1358.14fr of latent gain with 4194.82fr of employed capital.
  • The second momentum investment strategy would give 31.24% of return on ALCON N. That represents 678.76fr of latent gain with 2172.76fr of employed capital.
Performance at glance (1Q Momentum)

Performance

32.38 %

Latent gain

1358.14 fr

Invested capital

4194.82 fr

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

31.24 %

Latent gain

678.76 fr

Invested capital

2172.76 fr

Annualized return

13.95 %

Momentum equity curve on ALCON N

The following chart shows the equity curve of the two momentum strategies applied to ALCON N:

ALCON N momentum equity

Note: the dividends potentially given by ALCON N are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ALCON N

The following chart shows the employed capital evolution of the two momentum strategies on ALCON N since the beginning:

ALCON N

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250fr, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000fr.


Buy the dip strategy result on ALCON N

Buy the dip entry openings on ALCON N

ALCON N

The performance achieved by the robo-advisor on ALCON N is 0%. That represents 0.0$ of latent gain with 0.0fr of employed capital. The following chart shows ALCON N stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ALCON N, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 fr

Invested capital

0.0 fr

Annualized return

0.0 %

Equity curve of the strategy applied to ALCON N

The following chart shows the result of the investment strategy applied to ALCON N:

ALCON N

Note: the dividends potentially given by ALCON N are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ALCON N

The following chart shows the employed capital evolution since the beginning of the investment strategy on ALCON N:

ALCON N

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ALCON N

In this section, I will compare the three previous investment strategies applied to ALCON N.

Equity curve comparison on ALCON N

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ALCON N investment strategy comparison

Employed capital comparison on ALCON N

ALCON N investment comparison

Performance comparison on ALCON N

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 28.37% 281.9fr 993.78fr 10.43%
Momentum 1 quarter 32.38% 1358.14fr 4194.82fr 13.06%
Momentum 2 quarters 31.24% 678.76fr 2172.76fr 13.95%
Non-directional 0% 0.0fr 0.0fr 0.0%
Annualized return comparison

Automatic investment

10.43 %

Momentum 1Q

13.95 %

Momentum 2Q

13.95 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ALCON N:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between ALCON N and the other stocks. There may be false positives or some missing correlated stocks. If the price of ALCON N does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name ALCON N
Country Switzerland
City Geneva
Address Chemin de Blandonnet 8
Phone 41 58 911 20 00
Website www.alcon.com
FullTime employees 24000
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XSWX
Ticker ALC.XSWX
Market www.six-group.com

ALCON N ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown